GSA Capital Partners’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-105,551
| Closed | -$557K | – | 1919 |
|
|
2021
Q2 | $557K | Buy |
105,551
+84,538
| +402% | +$446K | 0.06% | 562 |
|
|
2021
Q1 | $101K | Buy |
+21,013
| New | +$101K | 0.02% | 1002 |
|
|
2020
Q3 | – | Sell |
-30,484
| Closed | -$78K | – | 1453 |
|
|
2020
Q2 | $78K | Sell |
30,484
-5,902
| -16% | -$15.1K | 0.04% | 512 |
|
|
2020
Q1 | $105K | Sell |
36,386
-30,527
| -46% | -$88.1K | 0.03% | 891 |
|
|
2019
Q4 | $254K | Buy |
+66,913
| New | +$254K | 0.03% | 1141 |
|
|
2018
Q3 | – | Sell |
-8,200
| Closed | -$212K | – | 2007 |
|
|
2018
Q2 | $212K | Buy |
+8,200
| New | +$212K | 0.01% | 1517 |
|
|
2016
Q1 | – | Sell |
-7,600
| Closed | -$215K | – | 1997 |
|
|
2015
Q4 | $215K | Sell |
7,600
-24,803
| -77% | -$702K | 0.01% | 1620 |
|
|
2015
Q3 | $542K | Buy |
+32,403
| New | +$542K | 0.03% | 1083 |
|
|
2015
Q2 | – | Sell |
-27,654
| Closed | -$484K | – | 2261 |
|
|
2015
Q1 | $484K | Buy |
27,654
+9,428
| +52% | +$165K | 0.02% | 1410 |
|
|
2014
Q4 | $317K | Buy |
18,226
+5,186
| +40% | +$90.2K | 0.02% | 1231 |
|
|
2014
Q3 | $243K | Buy |
+13,040
| New | +$243K | 0.01% | 1397 |
|